舒必利诱发的迟发性肌张力障碍。

Sulpiride-induced tardive dystonia.

作者信息

Miller L G, Jankovic J

机构信息

Department of Family Medicine, Baylor College of Medicine, Houston, Texas 77030.

出版信息

Mov Disord. 1990;5(1):83-4. doi: 10.1002/mds.870050119.

DOI:10.1002/mds.870050119

PMID:1967484

Abstract

Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties. Although initially thought to be free of extrapyramidal side effects, sulpiride-induced tardive dyskinesia and parkinsonism have been reported occasionally. We studied a 37-year-old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy. We could not find any previous reports of sulpiride-induced tardive dystonia.

摘要

舒必利是一种具有抗精神病和抗抑郁特性的选择性D2受体拮抗剂。尽管最初认为它没有锥体外系副作用，但偶尔也有关于舒必利诱发迟发性运动障碍和帕金森症的报道。我们研究了一名37岁男性，他在开始舒必利治疗后2个月内出现了持续性节段性肌张力障碍。我们未发现之前有关于舒必利诱发迟发性肌张力障碍的报道。